Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vaccine Effectiveness × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 3137 Uterine Cervical Neoplasms 2163 Endometrial Neoplasms 1316 Breast Neoplasms 811 Fallopian Tube Neoplasms 803 Carcinoma, Ovarian Epithelial 766 Neoplasms 538 Colorectal Neoplasms 434 Carcinoma, Non-Small-Cell Lung 413 Uterine Cervical Dysplasia 371 Pancreatic Neoplasms 361 Stomach Neoplasms 352 Prostatic Neoplasms 316 Lung Neoplasms 313 Melanoma 288 Uterine Neoplasms 237 Peritoneal Neoplasms 237 Neoplasm Metastasis 235 Vulvar Neoplasms 228 Urinary Bladder Neoplasms 226 Esophageal Neoplasms 225 Head and Neck Neoplasms 220 Sarcoma 218 Carcinoma, Renal Cell 211 Recurrence 209 Colonic Neoplasms 208 Papillomavirus Infections 202 Triple Negative Breast Neoplasms 190 Squamous Cell Carcinoma of Head and Neck 175 Vaginal Neoplasms 146

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡